Addus HomeCare (NASDAQ:ADUS) Cut to “Hold” at StockNews.com

StockNews.com downgraded shares of Addus HomeCare (NASDAQ:ADUS) from a buy rating to a hold rating in a research report released on Wednesday morning.

Several other equities analysts have also weighed in on the company. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, Stephens cut their price target on Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $95.77 on Wednesday. The stock has a 50-day simple moving average of $122.60 and a two-hundred day simple moving average of $126.08. The firm has a market capitalization of $1.74 billion, a P/E ratio of 21.92, a PEG ratio of 1.41 and a beta of 1.00. Addus HomeCare has a fifty-two week low of $87.88 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. As a group, analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Summit Place Financial Advisors LLC raised its position in shares of Addus HomeCare by 0.9% during the 4th quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company’s stock valued at $1,180,000 after buying an additional 80 shares during the period. Janney Montgomery Scott LLC raised its position in shares of Addus HomeCare by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock valued at $1,340,000 after buying an additional 91 shares during the period. Alliancebernstein L.P. raised its position in shares of Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company’s stock valued at $2,465,000 after buying an additional 91 shares during the period. New York State Teachers Retirement System raised its position in shares of Addus HomeCare by 1.2% during the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after buying an additional 100 shares during the period. Finally, Equitable Trust Co. raised its position in shares of Addus HomeCare by 2.2% during the 3rd quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after buying an additional 106 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.